Australia’s ‘Super-K’ flu strain sparks record global influenza outbreaks
January 5, 2026
Influenza A (H3N2) subclade K emerged in Australia and New Zealand in late winter 2025, with an extended flu season spreading across 30 countries worldwide.
Australian scientists have warned that the country’s record-breaking 2025 influenza season has fuelled the emergence of a fast-spreading “Super-K” strain, now driving unprecedented flu outbreaks worldwide.
The influenza A (H3N2) subclade K viruses were first detected in Australia and New Zealand in August 2025, during late winter. Unusually, the flu season extended into summer, creating conditions for wider viral spread. Since then, the strain has been identified in more than 30 countries, according to experts from Australia’s Peter Doherty Institute for Infection and Immunity. Official data from Australia’s National Notifiable Diseases Surveillance System recorded more than 427,000 influenza notifications in 2025 — around 21 per cent higher than in 2024. This marks the highest number since national reporting began in 2001. In the first nine months of the year alone, 977 influenza-related deaths were reported. In a December 2025 statement, the Doherty Institute explained that the subclade K viruses have undergone genetic “drift,” accumulating mutations in hemagglutinin — a key surface protein that allows the virus to enter human cells. “These changes mean the virus may be less well recognized by immune responses generated from previous infection or vaccination,” the institute said. Despite this, Australian hospital and general practice data show that vaccination continues to offer significant protection, reducing the risk of doctor visits and hospitalization by approximately 50 per cent. “Even when influenza viruses drift, vaccines continue to reduce severe disease complications and death,” said Harry Stannard, a medical scientist and PhD candidate at the Doherty Institute. In response to the evolving strain, Australian experts have updated two of the three influenza vaccine components for the 2026 Southern Hemisphere season, including the critical H3N2 component. “It is always a bit of a race to update the vaccine to give it the best chance of inducing immune responses that provide effective protection during our influenza season next year,” said Professor Patrick Reading, Director of the World Health Organization Collaborating Centre for Reference and Research on Influenza at the Doherty Institute. Professor Reading also emphasized the importance of sustained investment in influenza surveillance, vaccination programs and antiviral treatments to mitigate severe illness and reduce the impact of future flu seasons. |
EXPLORE FURTHER
|
Global study reveals massive hidden health burden from violence against women and childrenIntimate partner violence drives severe anxiety, self-harm, and deadly outcomes
|
|
San Francisco sues food giants for marketing harmful ultra-processed productsOne of the first US government lawsuits targets food giants including Kraft Heinz, Mondelez International, and Coca-Cola
|
